US Stock MarketDetailed Quotes

QLYS Qualys

Watchlist
  • 130.430
  • +0.210+0.16%
Trading Mar 25 14:21 ET
4.76BMarket Cap28.05P/E (TTM)

Qualys Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
9.58%607.57M
10.11%159.19M
8.36%153.87M
8.38%148.71M
11.57%145.81M
13.22%554.46M
10.49%144.57M
13.09%142M
14.44%137.21M
15.22%130.68M
Operating revenue
9.58%607.57M
10.11%159.19M
8.36%153.87M
8.38%148.71M
11.57%145.81M
13.22%554.46M
10.49%144.57M
13.09%142M
14.44%137.21M
15.22%130.68M
Cost of revenue
3.72%111.48M
7.03%29.04M
7.83%28.83M
-0.93%26.42M
0.91%27.2M
4.57%107.49M
-2.23%27.13M
2.87%26.74M
6.45%26.66M
12.30%26.95M
Gross profit
10.99%496.09M
10.83%130.15M
8.48%125.04M
10.63%122.29M
14.34%118.61M
15.52%446.97M
13.91%117.44M
15.76%115.26M
16.55%110.55M
16.00%103.73M
Operating expense
8.80%308.89M
6.28%80.74M
11.75%80.08M
9.61%74.23M
7.72%73.85M
10.73%283.9M
4.89%75.97M
8.21%71.66M
9.48%67.72M
22.67%68.55M
Selling and administrative expenses
13.61%197.04M
8.12%52.44M
16.64%51.18M
16.90%47.11M
13.64%46.32M
11.75%173.43M
8.70%48.5M
7.69%43.88M
8.72%40.3M
24.35%40.76M
-Selling and marketing expense
14.87%128.3M
6.64%34.06M
17.23%32.69M
22.50%32.15M
14.75%29.41M
14.88%111.69M
12.86%31.94M
11.31%27.88M
10.58%26.24M
27.24%25.63M
-General and administrative expense
11.33%68.74M
10.97%18.38M
15.59%18.49M
6.44%14.96M
11.77%16.91M
6.48%61.74M
1.49%16.56M
1.92%16M
5.42%14.06M
19.74%15.13M
Research and development costs
1.25%111.85M
3.03%28.3M
4.03%28.9M
-1.11%27.12M
-0.95%27.53M
9.18%110.47M
-1.22%27.47M
9.04%27.78M
10.62%27.42M
20.29%27.8M
Operating profit
14.80%187.2M
19.16%49.41M
3.12%44.95M
12.24%48.07M
27.24%44.76M
24.91%163.07M
35.20%41.47M
30.74%43.6M
29.81%42.83M
4.90%35.18M
Net non-operating interest income expense
52.52%25.78M
11.34%6.19M
31.70%6.76M
75.98%6.7M
155.44%6.12M
225.66%16.91M
145.50%5.56M
227.55%5.14M
353.99%3.81M
362.74%2.4M
Non-operating interest income
52.52%25.78M
11.34%6.19M
31.70%6.76M
75.98%6.7M
155.44%6.12M
225.66%16.91M
145.50%5.56M
227.55%5.14M
353.99%3.81M
362.74%2.4M
Other net income (expense)
-138.70%-3.16M
-417.32%-1.78M
185.45%605K
38.79%-587K
-547.69%-1.4M
35.08%-1.32M
-61.59%560K
34.20%-708K
43.92%-959K
69.58%-216K
Gain on sale of security
-357.96%-3.19M
-400.17%-1.78M
185.45%605K
-42.41%-591K
----
60.64%-697K
-60.85%592K
22.20%-708K
75.73%-415K
----
Other non- operating income (expenses)
105.43%34K
--0
----
100.74%4K
-547.69%-1.4M
-134.46%-626K
40.74%-32K
----
---544K
-359.57%-216K
Income before tax
17.45%209.82M
13.11%53.83M
8.95%52.32M
18.62%54.18M
32.46%49.49M
33.62%178.65M
38.36%47.59M
41.92%48.02M
42.20%45.68M
12.04%37.36M
Income tax
33.58%36.14M
40.95%9.87M
305.24%6.11M
1.14%10.41M
18.17%9.75M
5.24%27.06M
15.29%7M
-75.59%1.51M
86.30%10.3M
4.05%8.25M
Net income
14.57%173.68M
8.31%43.97M
-0.65%46.21M
23.71%43.77M
36.51%39.73M
40.38%151.6M
43.31%40.59M
68.17%46.52M
33.04%35.38M
14.54%29.11M
Net income continuous Operations
14.57%173.68M
8.31%43.97M
-0.65%46.21M
23.71%43.77M
36.51%39.73M
40.38%151.6M
43.31%40.59M
68.17%46.52M
33.04%35.38M
14.54%29.11M
Minority interest income
Net income attributable to the parent company
14.57%173.68M
8.31%43.97M
-0.65%46.21M
23.71%43.77M
36.51%39.73M
40.38%151.6M
43.31%40.59M
68.17%46.52M
33.04%35.38M
14.54%29.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.57%173.68M
8.31%43.97M
-0.65%46.21M
23.71%43.77M
36.51%39.73M
40.38%151.6M
43.31%40.59M
68.17%46.52M
33.04%35.38M
14.54%29.11M
Basic earnings per share
14.84%4.72
9.09%1.2
-0.79%1.26
23.96%1.19
36.71%1.08
46.26%4.11
46.67%1.1
76.39%1.27
39.13%0.96
21.54%0.79
Diluted earnings per share
15.38%4.65
10.19%1.19
0.00%1.24
23.16%1.17
36.36%1.05
47.08%4.03
45.95%1.08
74.65%1.24
41.79%0.95
20.31%0.77
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 9.58%607.57M10.11%159.19M8.36%153.87M8.38%148.71M11.57%145.81M13.22%554.46M10.49%144.57M13.09%142M14.44%137.21M15.22%130.68M
Operating revenue 9.58%607.57M10.11%159.19M8.36%153.87M8.38%148.71M11.57%145.81M13.22%554.46M10.49%144.57M13.09%142M14.44%137.21M15.22%130.68M
Cost of revenue 3.72%111.48M7.03%29.04M7.83%28.83M-0.93%26.42M0.91%27.2M4.57%107.49M-2.23%27.13M2.87%26.74M6.45%26.66M12.30%26.95M
Gross profit 10.99%496.09M10.83%130.15M8.48%125.04M10.63%122.29M14.34%118.61M15.52%446.97M13.91%117.44M15.76%115.26M16.55%110.55M16.00%103.73M
Operating expense 8.80%308.89M6.28%80.74M11.75%80.08M9.61%74.23M7.72%73.85M10.73%283.9M4.89%75.97M8.21%71.66M9.48%67.72M22.67%68.55M
Selling and administrative expenses 13.61%197.04M8.12%52.44M16.64%51.18M16.90%47.11M13.64%46.32M11.75%173.43M8.70%48.5M7.69%43.88M8.72%40.3M24.35%40.76M
-Selling and marketing expense 14.87%128.3M6.64%34.06M17.23%32.69M22.50%32.15M14.75%29.41M14.88%111.69M12.86%31.94M11.31%27.88M10.58%26.24M27.24%25.63M
-General and administrative expense 11.33%68.74M10.97%18.38M15.59%18.49M6.44%14.96M11.77%16.91M6.48%61.74M1.49%16.56M1.92%16M5.42%14.06M19.74%15.13M
Research and development costs 1.25%111.85M3.03%28.3M4.03%28.9M-1.11%27.12M-0.95%27.53M9.18%110.47M-1.22%27.47M9.04%27.78M10.62%27.42M20.29%27.8M
Operating profit 14.80%187.2M19.16%49.41M3.12%44.95M12.24%48.07M27.24%44.76M24.91%163.07M35.20%41.47M30.74%43.6M29.81%42.83M4.90%35.18M
Net non-operating interest income expense 52.52%25.78M11.34%6.19M31.70%6.76M75.98%6.7M155.44%6.12M225.66%16.91M145.50%5.56M227.55%5.14M353.99%3.81M362.74%2.4M
Non-operating interest income 52.52%25.78M11.34%6.19M31.70%6.76M75.98%6.7M155.44%6.12M225.66%16.91M145.50%5.56M227.55%5.14M353.99%3.81M362.74%2.4M
Other net income (expense) -138.70%-3.16M-417.32%-1.78M185.45%605K38.79%-587K-547.69%-1.4M35.08%-1.32M-61.59%560K34.20%-708K43.92%-959K69.58%-216K
Gain on sale of security -357.96%-3.19M-400.17%-1.78M185.45%605K-42.41%-591K----60.64%-697K-60.85%592K22.20%-708K75.73%-415K----
Other non- operating income (expenses) 105.43%34K--0----100.74%4K-547.69%-1.4M-134.46%-626K40.74%-32K-------544K-359.57%-216K
Income before tax 17.45%209.82M13.11%53.83M8.95%52.32M18.62%54.18M32.46%49.49M33.62%178.65M38.36%47.59M41.92%48.02M42.20%45.68M12.04%37.36M
Income tax 33.58%36.14M40.95%9.87M305.24%6.11M1.14%10.41M18.17%9.75M5.24%27.06M15.29%7M-75.59%1.51M86.30%10.3M4.05%8.25M
Net income 14.57%173.68M8.31%43.97M-0.65%46.21M23.71%43.77M36.51%39.73M40.38%151.6M43.31%40.59M68.17%46.52M33.04%35.38M14.54%29.11M
Net income continuous Operations 14.57%173.68M8.31%43.97M-0.65%46.21M23.71%43.77M36.51%39.73M40.38%151.6M43.31%40.59M68.17%46.52M33.04%35.38M14.54%29.11M
Minority interest income
Net income attributable to the parent company 14.57%173.68M8.31%43.97M-0.65%46.21M23.71%43.77M36.51%39.73M40.38%151.6M43.31%40.59M68.17%46.52M33.04%35.38M14.54%29.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.57%173.68M8.31%43.97M-0.65%46.21M23.71%43.77M36.51%39.73M40.38%151.6M43.31%40.59M68.17%46.52M33.04%35.38M14.54%29.11M
Basic earnings per share 14.84%4.729.09%1.2-0.79%1.2623.96%1.1936.71%1.0846.26%4.1146.67%1.176.39%1.2739.13%0.9621.54%0.79
Diluted earnings per share 15.38%4.6510.19%1.190.00%1.2423.16%1.1736.36%1.0547.08%4.0345.95%1.0874.65%1.2441.79%0.9520.31%0.77
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Wintech Nano
688757
+202.42%
CHANGFU CO.,LTD
871396
+29.97%
DIER CHEMICAL
831304
+27.61%
4
CHENGUANG MEDICAL
430300
+21.92%
5
TLC
873576
+20.34%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Earnings Season Underway
Earnings season is here. What to know?